Photocatalytic activity and antibacterial properties of linen fabric using reduced graphene oxide/silver nanocomposite

Silver nanoparticles were in situ prepared on the surface of linen fabric coated by graphene oxide (GO). In the meantime, the reduction of silver nitrate on the GO-coated fabric led to the synthesis of reduced graphene oxide on the fabric. Two kinds of substrate (cotton and linen) were used. Both RGO/Ag and Ag/GO nanocomposites were added on cotton and linen fabrics through a conventional “pad–dry–cure” method. The chemistry and morphology of the coated surfaces were extensively characterized using Fourier-transformed infrared spectroscopy, energy-dispersive X-ray spectroscopy, and scanning electron microscopy. Resistivity measurements were used for assessing the conductivity. The UV protection properties and the photocatalytic activity of the coated fabrics against methylene blue dye were also investigated. The antibacterial activity was studied against Gram-positive S. aureus and B. subtilis and Gram-negative bacterial strains E. coli and P. aeruginosa by determining the zone of inhibition using the agar diffusion method. Methicillin-resistant Staphylococcus aureus (MRSA) has been responsible for many serious hospital infections worldwide. The fabrics showed superior antibacterial activity and successfully hindered the growth of pathogenic bacterial strains. This outcome suggested that both the RGO/Ag and Ag/GO nanocomposites-coated fabrics could be potentially applied in biomaterials and biomedical fields.

Silver nanoparticles were in situ prepared on the surface of linen fabric coated by graphene oxide (GO).     

Correction: Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 Mpro

Correction for ‘Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 M^pro’ by Vishal M. Balaramnavar et al., RSC Adv., 2020, 10, 40264–40275, DOI: 10.1039/D0RA06038K.

The authors regret that the name of one of the authors (Talha Jawaid) was shown incorrectly in the original article. The corrected author list is as shown above.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.     

The prevalence of osteoporosis/osteopenia in patients with multiple sclerosis (MS): a systematic review and meta-analysis

Neurological Sciences - The prevalence of osteoporosis is reported differently. We designed this systematic review and meta-analysis to estimate pooled prevalence of osteoporosis and osteopenia in...     

Dual inhibition of cyclooxygenase and lipoxygenase enzymes by human cerebrospinal fluid

Thromboxane A₂ (TXA₂) formed in damaged brain tissue and after thromboembolism and subarachnoid haemorrhage is responsible for cerebral vasospasm. In the present study, we examined the effect of human cerebrospinal fluid (CSF) on the production of thromboxane-A₂ (TXA₂) and 12-hydroxy-eicosatetraenoic acid (12-HETE) by human blood platelets. CSF was drawn by lumbar puncture from normal healthy volunteers (n = 17) and samples judged to be normal after routine examination in the clinical laboratories and were used fresh. We found that CSF inhibited the production of TXA₂ and 12-HETE by blood platelets incubated with C¹⁴ labelled arachidonic acid (AA) in a concentration-related manner. Further biochemical analysis using proteolytic enzymes, gel filtration and membrane partition chromatography showed that the inhibitory activity was peptidic in nature and associated with a peptide of low molecular weight (1,400 Da). This study is the first to demonstrate that human CSF contains a dual inhibitor of cyclooxygenase (COX) and lipoxygenase enzymes in CSF.     

Herbal and dietary supplements for treatment of anxiety disorders

Use of complementary and alternative medicine has increased over the past decade. A variety of studies have suggested that this use is greater in persons with symptoms or diagnoses of anxiety and depression. Data support the effectiveness of some popular herbal remedies and dietary supplements; in some of these products, particularly kava, the potential for benefit seems greater than that for harm with short-term use in patients with mild to moderate anxiety. Inositol has been found to have modest effects in patients with panic disorder or obsessive-compulsive disorder. Physicians should not encourage the use of St. John's wort, valerian, Sympathyl, or passionflower for the treatment of anxiety based on small or inconsistent effects in small studies. Although the evidence varies depending on the supplement and the anxiety disorder, physicians can collaborate with patients in developing dietary supplement strategies that minimize risks and maximize benefits.